Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NXT +21.8%, FFIV +13.3%, EAT +10.5%, TMUS +7.4%, ASML +5.9%, GLW +5.4%, EXTR +5.2%, VIRT +4.5%, LRN +4.3%, SF +4.3%, SMG +4.2%, LOGI +4.1%, VFC +2.7%, FCF +2.3%, SBUX +2.1%, SLGN +2.1%, NAVI +2%, ASH +1.2%, ADP +1.2%, GPI +1.1%,
Other news:
- CGEM +14.8% (Cullinan Therapeutics, Taiho Pharmaceutical and Taiho Oncology Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy)
- PACK +10.3% (details Amazon.com (AMZN) Transaction Agreement for warrant to purchase common stock)
- FNA +9.2% (Paragon 28 to be acquired by Zimmer Biomet for upfront payment of $13.00 per share)
- AZUL +8.8% (concludes restructuring process; eliminating $2.1 billion in debt and financial obligations and receiving $525 million in new capital)
- AHH +3.7% (updates strategic steps in its balance sheet management strategy)
- HSIC +3.2% (confirms strategic investment by KKR (KKR); sees Q4 EPS and revs below consensus; provides FY25 guidance; authorized an increase of $500 million to the company's stock repurchase program)
- HAFC +2.7% (increases dividend)
- SYNA +2.1% (SYNA accelerates Edge AI strategy by signing licensing agreement with AVGO)
- ASPN +2% (resolves patent dispute with AMA)
- SEDG +1.9% (in sympathy with strong NXT earnings)
- AVGO +1.8% (SYNA accelerates Edge AI strategy by signing licensing agreement with AVGO)
- ETNB +1.8% (prices $250.0 mln offering of common stock and pre-funded warrants)
- SES +1.8% (signed a non-binding Memorandum of Understanding with AISPEX)
- ENPH +1.7% (in sympathy with strong NXT earnings)
- FSLR +1.7% (in sympathy with strong NXT earnings)
- SONY +1.6% (approved a new management structure effective April 1, 2025 at a meeting of its Board of Directors held today)
- NOG +1.5% (increases dividend)
- ULCC +1.5% (confirms that it has had preliminary confidential discussions with Spirit and has made a proposal to combine with Spirit (SAVE / SAVEQ))
- RUN +1.1% (in sympathy with strong NXT earnings)
- AKRO +1% (prices offering of common stock and pre-funded warrants)